| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.16 | 0.06 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.054 | 0.06 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |